Viewing Study NCT00000295


Ignite Creation Date: 2025-12-24 @ 1:32 PM
Ignite Modification Date: 2026-01-01 @ 9:35 PM
Study NCT ID: NCT00000295
Status: COMPLETED
Last Update Posted: 2017-01-12
First Post: 1999-09-20
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Progesterone Treatment in Female Smokers - 12
Sponsor: National Institute on Drug Abuse (NIDA)
Organization:

Study Overview

Official Title: Progesterone Treatment in Female Smokers
Status: COMPLETED
Status Verified Date: 1999-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to investigate progesterone effects in female smokers
Detailed Description: Limited research has been done on the effects of gender and menstrual cycle in response to drugs of abuse in humans. The main goal of this pilot study is to investigate the safety and tolerability of progesterone treatment in female nicotine users. In addition, plasma progesterone levels reached with a single 200 mg dose of progesterone treatment will be measured. The study will be a double-blind placebo controlled, crossover trial in which 12 female smokers who are in the early follicular phase of their menstrual cycle will be enrolled. Druing the experimental sessions, subjects will be given a single 200 mg dose of micronized progesterone or placebo and multiple blood samples will be obtained to measure the plasma levels of progesterone. Starting 2 hours after progesterone or placebo treatment, subjects will have a self-administration period that will last around 2.5 hours. We hypothesize that administration of 200 mg of progesterone will achieve plasma progesterone concentrations similar to those found in the luteal phase of the menstrual cycle, 3-30 ng/ml.

Study Oversight

Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
P50-09259-12 None None View